logo

For the Inventor, By the Inventor

Jerusalem, Israel

Hadasit Medical Research Services and Development Ltd.


USPTO Granted Patents = 169



Forward Citations = 473

Loading Chart...
Loading Chart...

337 inventors (with patents filed for the assignee):

goldMedal Yaron Ilan (16 out of 47 patents)

silverMedal Benjamin Eithan Reubinoff (15 out of 25 patents)

bronzeMedal Israel Vlodavsky (9 out of 33 patents)

4.  Shimon Slavin (8 out of 24 patents)

5.  Iris Pecker (8 out of 26 patents)

6.  Tony Peled (7 out of 22 patents)

7.  Yaakov Naparstek (7 out of 13 patents)

8.  Eitan Fibach (7 out of 9 patents)

9.  Yoav Mintz (6 out of 6 patents)

10.  Eithan Galun (6 out of 10 patents)

11.  Avi Treves (6 out of 10 patents)

12.  Rifaat Safadi (5 out of 6 patents)

13.  Raphael Gorodetsky (5 out of 14 patents)

14.  Eyal Yosef Mishani (5 out of 6 patents)

15.  Michal Lotem (5 out of 5 patents)


Core Competencies:
Multiple Sclerosis
Neurodegenerative Diseases
Inflammatory Bowel Disease
Retinal Diseases
Glycogen Storage Disorders
Cancer Therapy
Machine Learning
Extracellular Vesicles
Thrombopoiesis
Liver Disorders
Endotracheal Intubation
Tissue Regeneration

169 patents:

1. 12448651 - Markers of disease prognosis in multiple sclerosis (2025-10-21),
2. 12419834 - Pomegranate oil for preventing and treating neurodegenerative diseases (2025-09-23),
3. 12409190 - Milk derived extracellular vesicles for use in treating inflammatory bowel disease (2025-09-09),
4. 12329884 - Devices, kits and methods for reducing and/or preventing intra-abdominal adhesions (2025-06-17),
5. 12317892 - Micro and nanoparticulate compositions comprising anti-microbially active groups (2025-06-03),
6. 12281328 - Photoreceptor cells for the treatment of retinal diseases (2025-04-21),
7. 12188047 - Preparation of retinal pigment epithelium cells (2025-01-07),
8. 12065435 - Compounds for the treatment of glycogen storage disorders (2024-08-20),
9. 11952431 - Neutrophil-binding peptides (2024-04-09),
10. 11891381 - Compounds for the treatment of glycogen storage disorders (2024-02-06),
11. 11872328 - Devices, kits and methods for reducing and/or preventing intra-abdominal adhesions (2024-01-16),
12. 11865090 - Tumor suppressive microRNAs for cancer therapy (2024-01-09),
13. 11853855 - Machine learning detection and classification of maxillofacial bone lesions in CBCT (2023-12-26),
14. 11834487 - Modulation of SLAMF6 splice variants for cancer therapy (2023-12-05),
15. 11801220 - Pomegranate oil for preventing and treating neurodegenerative diseases (2023-10-31),
Hadasit Medical Research Services and Development Ltd. is a leading Israeli technology transfer company, specializing in commercializing cutting-edge innovations from Hadassah Medical Organization. With a strong track record of successful collaborations with industry partners and investors, Hadasit aims to bring life-saving technologies to market and improve patient care worldwide.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

169 Patents

#3 in Jerusalem

#28 in Israel

#4,761 in the World

...
Jerusalem, Israel

Hadasit Medical Research Services and Development Ltd.

Forward Citations = 473

337 inventors:

goldMedal Yaron Ilan (16 out of 47 patents)

silverMedal Benjamin Eithan Reubinoff (15 out of 25 patents)

bronzeMedal Israel Vlodavsky (9 out of 33 patents)

4.  Shimon Slavin (8 out of 24 patents)

5.  Iris Pecker (8 out of 26 patents)

Please report any incorrect information to support@idiyas.com
Loading…